Chenia H Y, Pillay B, Hoosen A A, Pillay D
Department of Microbiology, University of Durban-Westville, South Africa.
Sex Transm Dis. 1997 Jan;24(1):18-22. doi: 10.1097/00007435-199701000-00005.
The appearance of strains of Neisseria gonorrhoeae resistant, both chromosomally and plasmid-mediated, to penicillin and other antibiotics makes this versatile pathogen difficult to treat. There is, therefore, a need for surveillance of N. gonorrhoeae strains to determine the efficacy of current therapeutic measures.
To survey the antibiotic susceptibilities and plasmid profiles of penicillinase-producing N. gonorrhoeae strains isolated over a 4-year period.
Penicillinase-producing N. gonorrhoeae strains were detected by the chromogenic cephalosporin test. Minimum inhibitory concentrations to penicillin G, tetracycline, ceftriaxone, and ciprofloxacin were determined using the E-test. Plasmid DNA was obtained by the alkaline lysis method and profiles generated.
Penicillinase-producing N. gonorrhoeae strains increased from 16.4% to 19.0% in the period from 1990 through 1993. Although all strains were resistant to penicillin, strains were susceptible to varying levels of ciprofloxacin, ceftriaxone, and even tetracycline. All penicillinase-producing N. gonorrhoeae strains possessed the 2.6-megadalton cryptic plasmid, and in addition 87.7% contained the 24.5-megadalton conjugative plasmid. Of the six known gonococcal beta-lactamase plasmids, the 4.4-megadalton Asian and 3.2-megadalton African plasmids were predominant. The most prevalent plasmid profile contained the 2.6-megadalton cryptic, 24.5-megadalton conjugative, and 4.4-megadalton Asian plasmids.
To ensure effective treatment of gonorrhea, continued surveillance of the antimicrobial susceptibilities and plasmid profiles of penicillinase-producing N. gonorrhoeae strains is necessary.
淋病奈瑟菌出现了对青霉素及其他抗生素具有染色体介导和质粒介导耐药性的菌株,使得这种具有多种特性的病原体难以治疗。因此,有必要对淋病奈瑟菌菌株进行监测,以确定当前治疗措施的疗效。
调查在4年期间分离出的产青霉素酶淋病奈瑟菌菌株的抗生素敏感性和质粒图谱。
通过显色头孢菌素试验检测产青霉素酶淋病奈瑟菌菌株。使用E试验确定对青霉素G、四环素、头孢曲松和环丙沙星的最低抑菌浓度。通过碱性裂解方法获得质粒DNA并生成图谱。
在1990年至1993年期间,产青霉素酶淋病奈瑟菌菌株从16.4%增加到19.0%。虽然所有菌株对青霉素耐药,但对不同水平的环丙沙星、头孢曲松甚至四环素敏感。所有产青霉素酶淋病奈瑟菌菌株都拥有2.6兆道尔顿的隐蔽质粒,此外87.7%含有24.5兆道尔顿的接合质粒。在六种已知的淋球菌β-内酰胺酶质粒中,4.4兆道尔顿的亚洲质粒和3.2兆道尔顿的非洲质粒占主导地位。最常见的质粒图谱包含2.6兆道尔顿的隐蔽质粒、24.5兆道尔顿的接合质粒和4.4兆道尔顿的亚洲质粒。
为确保淋病的有效治疗,有必要持续监测产青霉素酶淋病奈瑟菌菌株的抗菌药物敏感性和质粒图谱。